Research analysts at HC Wainwright lowered their Q1 2025 EPS estimates for Genelux in a report released on Monday, March 31st ...
Equities research analysts at HC Wainwright issued their Q3 2025 EPS estimates for shares of Defiance Silver in a research ...
H.C. Wainwright sees increased uncertainty for Sarepta’s Elevidys franchise after the European Medicines Agency placed a clinical hold on three drug trials. The clinical hold on ...
H.C. Wainwright raised the firm’s price target on Compass Therapeutics (CMPX) to $24 from $10 and keeps a Buy rating on the shares. The company ...
AMERICAN REBEL ANNOUNCES UP TO $11 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
Nashville, TN, April 04, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved ...
2h
Stocktwits on MSNSarepta Therapeutics Temporarily Halts Three Clinical Studies Of Elevidys: Retail Is Dull While Stock DropsShares of Sarepta Therapeutics, Inc. (SRPT) traded over 2% lower in afternoon trade on Friday after the company said it has ...
Analysts have set 12-month price targets for Orchestra BioMed Hldgs, revealing an average target of $14.5, a high estimate of ...
Two days after announcing his sweeping tariffs, U.S. President Donald Trump provided an update on a crucial trading partner – Vietnam. Trump said he had a “constructive call” with To Lam, General ...
Sarepta Therapeutics (NASDAQ:SRPT) announced Friday that the company and its partner Roche (OTCQX:RHHBY) expect to provide EU ...
Mark Jones makes 10 changes and Dwayne Peel just two for Sunday's European Challenge Cup follow-up to Scarlets URC win against Ospreys.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results